CrossRef High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis Zi-Rui Zhang, Ling She, Yi-Rong Cao, Yuan-Wen Chen World Journal of Hepatology .2026;[Epub] CrossRef Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease Allen Anthony Larao, Silvia Palmisano, Deborah Bonazza, Discipio Marina, Marica Meroni, Anna Ludovica Fracanzani, Lory S Croc, Claudio Tiribelli, Paola Dongiovanni, Natalia Rosso, Pablo Giraudi Annals of Hepatology .2026
Retrieved 9 March 2016
Tchangs point is that it there is precedence for doing this already, despite those drugs being ineffective: I dont think of Orlistat as an obesity medication anymore because it doesnt really target the root cause of obesity
Always consult your GP or prescribing clinician before combining any medications to ensure the approach is safe and appropriate for your individual circumstances
Tips for Stopping or Restarting a GLP-1 If you need to stop and restart your GLP-1, here is how you can do it most safely